We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$16.7M
Cap. Flow
-$84.9M
Cap. Flow %
-4.82%
Top 10 Hldgs %
24.37%
Holding
275
New
15
Increased
54
Reduced
181
Closed
13

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$12.2M
2
PCRX icon
Pacira BioSciences
PCRX
+$12.2M
3
DOCS icon
Doximity
DOCS
+$8.19M
4
ESTA icon
Establishment Labs
ESTA
+$6.27M
5
COLB icon
Columbia Banking Systems
COLB
+$5M

Top Sells

Rank Stock Value
1
IAA
IAA, Inc. Common Stock
IAA
+$17.7M
2
MED icon
Medifast
MED
+$17.2M
3
ALBO
Albireo Pharma Inc
ALBO
+$11.1M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$6.11M
5
WNS
WNS Holdings
WNS
+$5.97M

Sector Composition

Rank Sector Weight
1 Healthcare 27.26%
2 Technology 26.93%
3 Industrials 17.12%
4 Consumer Discretionary 9.62%
5 Communication Services 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FC icon
26
Franklin Covey
FC
$246M
$16.9M 0.96%
439,998
+77,628
+21% +$3.58M
MTN icon
27
Vail Resorts
MTN
$5.3B
$16.9M 0.96%
72,302
-6,310
-8% -$1.52M
ACAD icon
28
Acadia Pharmaceuticals
ACAD
$5.03B
$16.7M 0.95%
887,126
-70,562
-7% -$1.34M
ASND icon
29
Ascendis Pharma A/S
ASND
$16.8B
$16.6M 0.94%
154,928
+9,189
+6% +$1.05M
BBBY
30
Bed Bath & Beyond
BBBY
$442M
$16.5M 0.94%
894,979
+38,014
+4% +$709K
PGTI
31
DELISTED
PGT, Inc.
PGTI
$16.1M 0.92%
642,569
-50,801
-7% -$1.08M
MMS icon
32
Maximus
MMS
$3.1B
$16M 0.91%
203,148
-20,644
-9% -$1.59M
CMBM
33
DELISTED
Cambium Networks
CMBM
$15.6M 0.88%
878,373
-43,192
-5% -$879K
POOL icon
34
Pool Corp
POOL
$7.5B
$15.5M 0.88%
45,239
-3,554
-7% -$1.26M
CEVA icon
35
CEVA Inc
CEVA
$1.08B
$14.4M 0.82%
473,905
-30,678
-6% -$961K
NBIX icon
36
Neurocrine Biosciences
NBIX
$16.6B
$13.9M 0.79%
137,237
-12,130
-8% -$1.26M
SMTC icon
37
Semtech
SMTC
$13B
$13.7M 0.78%
568,697
-26,331
-4% -$823K
QLYS icon
38
Qualys
QLYS
$6.35B
$13.3M 0.75%
102,141
-8,958
-8% -$1.05M
LMAT icon
39
LeMaitre Vascular
LMAT
$1.86B
$13.1M 0.74%
254,466
-836
-0.3% -$40.6K
OZK icon
40
Bank OZK
OZK
$5.61B
$12.9M 0.73%
378,184
-30,752
-8% -$1.29M
PRGS icon
41
Progress Software
PRGS
$1.76B
$12.9M 0.73%
224,258
-1,829
-0.8% -$102K
MED icon
42
Medifast
MED
$141M
$11.8M 0.67%
113,468
-155,629
-58% -$17.2M
RBA icon
43
RB Global
RBA
$17.5B
$11.7M 0.66%
+207,333
New +$12.2M
WIX icon
44
WIX.com
WIX
$2.52B
$11.3M 0.64%
113,555
-9,814
-8% -$862K
UTMD icon
45
Utah Medical Products
UTMD
$225M
$10.8M 0.61%
114,123
-243
-0.2% -$22.3K
IOVA icon
46
Iovance Biotherapeutics
IOVA
$2.87B
$10.6M 0.6%
1,729,964
-92,116
-5% -$636K
OABI icon
47
OmniAb
OABI
$447M
$10.4M 0.59%
2,820,102
+336,336
+14% +$1.27M
XPO icon
48
XPO
XPO
$23.7B
$10.1M 0.57%
315,271
-27,505
-8% -$991K
CNTY icon
49
Century Casinos
CNTY
$34M
$9.6M 0.55%
1,310,285
-61,672
-4% -$515K
FOLD
50
DELISTED
Amicus Therapeutics
FOLD
$9.39M 0.53%
846,859
+138,971
+20% +$1.71M
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Rice Hall James & Associates held 275 positions worth $1.76B, up 0.96% from $1.74B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $84.9M in Q1 2023, closing 13 positions and reducing 181 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in RB Global worth $11.7M.

  • Rice Hall James & Associates's largest Q1 2023 buy was RB Global: 207,333 shares worth $11.7M.
  • Rice Hall James & Associates added most to Pacira BioSciences in Q1 2023, an estimated $12.2M increase.
  • Rice Hall James & Associates's biggest Q1 2023 reduction was Medifast, cutting an estimated $17.2M.
  • Rice Hall James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $17.7M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.76B portfolio in Q1 2023.
  • Rice Hall James & Associates opened 15 new positions and closed 13 in Q1 2023.
  • Rice Hall James & Associates's portfolio value rose 0.96% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q1 2023, filed 12 May 2023.